GELTEX PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: GELTEX PHARMACEUTICALS INC, 10-Q, EX-10.9, 2000-11-14
Next: GIBBS CONSTRUCTION INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                      71,178,825
<SECURITIES>                                68,427,498
<RECEIVABLES>                                9,880,948
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           152,181,678
<PP&E>                                      19,998,729
<DEPRECIATION>                               6,460,469
<TOTAL-ASSETS>                             189,355,644
<CURRENT-LIABILITIES>                        7,377,334
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       215,485
<OTHER-SE>                                 175,839,394
<TOTAL-LIABILITY-AND-EQUITY>               189,355,644
<SALES>                                              0
<TOTAL-REVENUES>                            36,910,790
<CGS>                                                0
<TOTAL-COSTS>                               32,935,082
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             546,292
<INCOME-PRETAX>                              8,502,563
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          8,502,563
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 8,502,563
<EPS-BASIC>                                       0.43
<EPS-DILUTED>                                     0.41


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission